2-21002881-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000384.3(APOB):​c.12541G>A​(p.Glu4181Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.168 in 1,612,886 control chromosomes in the GnomAD database, including 23,921 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E4181D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.16 ( 2057 hom., cov: 31)
Exomes 𝑓: 0.17 ( 21864 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: -0.151

Publications

125 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026869774).
BP6
Variant 2-21002881-C-T is Benign according to our data. Variant chr2-21002881-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128417.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.18 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.12541G>Ap.Glu4181Lys
missense
Exon 29 of 29NP_000375.3P04114

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.12541G>Ap.Glu4181Lys
missense
Exon 29 of 29ENSP00000233242.1P04114

Frequencies

GnomAD3 genomes
AF:
0.165
AC:
25020
AN:
151820
Hom.:
2054
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.153
Gnomad AMI
AF:
0.132
Gnomad AMR
AF:
0.145
Gnomad ASJ
AF:
0.149
Gnomad EAS
AF:
0.0458
Gnomad SAS
AF:
0.0930
Gnomad FIN
AF:
0.222
Gnomad MID
AF:
0.124
Gnomad NFE
AF:
0.183
Gnomad OTH
AF:
0.179
GnomAD2 exomes
AF:
0.153
AC:
38224
AN:
249978
AF XY:
0.154
show subpopulations
Gnomad AFR exome
AF:
0.154
Gnomad AMR exome
AF:
0.122
Gnomad ASJ exome
AF:
0.150
Gnomad EAS exome
AF:
0.0484
Gnomad FIN exome
AF:
0.212
Gnomad NFE exome
AF:
0.182
Gnomad OTH exome
AF:
0.162
GnomAD4 exome
AF:
0.169
AC:
246533
AN:
1460948
Hom.:
21864
Cov.:
37
AF XY:
0.167
AC XY:
121538
AN XY:
726684
show subpopulations
African (AFR)
AF:
0.150
AC:
5031
AN:
33438
American (AMR)
AF:
0.124
AC:
5551
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.145
AC:
3777
AN:
26096
East Asian (EAS)
AF:
0.0440
AC:
1745
AN:
39688
South Asian (SAS)
AF:
0.102
AC:
8812
AN:
86088
European-Finnish (FIN)
AF:
0.204
AC:
10874
AN:
53280
Middle Eastern (MID)
AF:
0.124
AC:
717
AN:
5760
European-Non Finnish (NFE)
AF:
0.180
AC:
200535
AN:
1111636
Other (OTH)
AF:
0.157
AC:
9491
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
11289
22578
33866
45155
56444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6888
13776
20664
27552
34440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.165
AC:
25037
AN:
151938
Hom.:
2057
Cov.:
31
AF XY:
0.164
AC XY:
12185
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.152
AC:
6316
AN:
41418
American (AMR)
AF:
0.145
AC:
2212
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.149
AC:
517
AN:
3472
East Asian (EAS)
AF:
0.0461
AC:
238
AN:
5160
South Asian (SAS)
AF:
0.0949
AC:
457
AN:
4814
European-Finnish (FIN)
AF:
0.222
AC:
2342
AN:
10558
Middle Eastern (MID)
AF:
0.123
AC:
36
AN:
292
European-Non Finnish (NFE)
AF:
0.183
AC:
12426
AN:
67932
Other (OTH)
AF:
0.177
AC:
373
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1048
2096
3143
4191
5239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.174
Hom.:
11044
Bravo
AF:
0.159
TwinsUK
AF:
0.184
AC:
684
ALSPAC
AF:
0.193
AC:
745
ESP6500AA
AF:
0.148
AC:
652
ESP6500EA
AF:
0.175
AC:
1508
ExAC
AF:
0.153
AC:
18532
EpiCase
AF:
0.182
EpiControl
AF:
0.190

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
3
Familial hypercholesterolemia (3)
-
-
2
Familial hypobetalipoproteinemia 1 (2)
-
-
2
Hypercholesterolemia, autosomal dominant, type B (2)
-
-
2
Hypercholesterolemia, familial, 1 (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
4.6
DANN
Benign
0.92
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.24
N
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-0.99
T
PhyloP100
-0.15
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.014
Sift
Benign
0.26
T
Sift4G
Benign
0.34
T
Vest4
0.10
MPC
0.040
ClinPred
0.00044
T
GERP RS
0.15
gMVP
0.26
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1042031; hg19: chr2-21225753; COSMIC: COSV51923204; COSMIC: COSV51923204; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.